International Lymphoma Epidemiology Consortium
- Overview
- Funding Sources
- Organizational Structure
- Objectives
- Membership
- Publications
- Annual Meetings
- Contacts
Overview
The InterLymph Consortium, or formally the International Consortium of Investigators Working on Non-Hodgkin's Lymphoma Epidemiologic Studies, is an open scientific forum for epidemiologic research in non-Hodgkin's lymphoma. Formed in 2001, the Consortium is a group of international investigators who have completed or have ongoing case-control studies and who discuss and undertake research projects that pool data across studies or otherwise undertake collaborative research.
Funding Sources
Support for logistical needs of the Consortium is provided by NCI's Division of Cancer Epidemiology and Genetics
(DCEG), which is the intramural (in-house) research component of the Institute, and the Epidemiology and Genomics Research Program (EGRP) of the Division of Cancer Control and Population Sciences (DCCPS), which manages the epidemiology grant program for the Institute; the International Agency for Research on Cancer (IARC); and the Leukaemia Research Fund. Some investigators within the Consortium also have grant support for research projects.
Organizational Structure
InterLymph is led by a Coordinating Committee, which has a rotating membership. View list of current Coordinating Committee members.
The Consortium consists of five working groups focused on genetics, Hodgkin's lymphoma, immunity and infection, and pathology and survival. View a list of contacts for each of the working groups.
Objectives
Within the scope defined by its Mission, the objectives of InterLymph are to expand knowledge of lymphoma etiology through:
- Fostering collaborations between researchers in different countries;
- Providing a framework for the efficient conduct and publication of original data meta-analyses of relevant studies;
- Providing a forum and framework for discussion, development and pursuit of new research directions; and
- Supporting the development of early career researchers.
Membership
InterLymph welcomes researchers interested in pursuing epidemiologic or etiological studies of non-Hodgkin and/or Hodgkin lymphoma that would allow contribution to and/or participation in pooled studies.
If you are a researcher who is interested in becoming an InterLymph member, please contact Aaron Norman to request information about membership.
Publications
InterLymph investigators have jointly published more than 20 scientific manuscripts since 2005.
View a list of InterLymph publications.
Annual Meetings
The InterLymph Consortium and its five working groups conducts annual meetings to discuss, coordinate and develop ongoing and future research projects. The 2013 InterLymph Annual Meeting will be held June 24-26 in Dijon, France. Learn more about InterLymph annual meetings.
Contacts
NCI Contacts- Martha Linet, M.D., M.P.H., Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI
- Rao L. Divi, Ph.D., Epidemiology and Genomics Research Program, DCCPS, NCI
- Aaron Norman, M.P.H., Administrative Services - Research, Mayo Clinic
